Abiomed
ABMD
#1257
Rank
NZ$29.73 B
Marketcap
NZ$659.55
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Net assets

Net assets on the balance sheet as of September 2022 : NZ$2.66 Billion

According to Abiomed's latest financial reports the company has NZ$2.66 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Abiomed - Net assets on balance sheet (from 2013 to 2022)

Net assets by year

Year Net assets Change
2022-03-31$NZ$2.16 B13.87%
2021-03-31$NZ$1.90 B6.35%
2020-03-31$NZ$1.79 B30.4%
2019-03-31$NZ$1.37 B44.07%
2018-03-31$NZ$0.95 B47.84%
2017-03-31$NZ$0.64 B20.97%
2016-03-31$NZ$0.53 B36.07%
2015-03-31$NZ$0.39 B101.82%
2014-03-31$NZ$0.19 B18.56%
2013-03-31$NZ$0.16 B6.36%
2012-03-31$NZ$0.15 B11.74%
2011-03-31$NZ$0.13 B-9.73%
2010-03-31$NZ$0.15 B-25.43%
2009-03-31$NZ$0.20 B75.71%
2008-03-31$NZ$0.11 B-31.77%
2007-03-31$NZ$0.17 B48.62%
2006-03-31$NZ$0.11 B45.39%
2005-03-31$NZ$78.97 M-2.99%
2004-03-31$NZ$81.4 M-27.41%
2003-03-31$NZ$0.11 B-37.7%
2002-03-31$NZ$0.17 B-34.23%
2001-03-31$NZ$0.27 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Teleflex
TFX
NZ$6.61 B 148.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$40.90 B 1,434.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
NZ$0.82 B-69.05%๐Ÿ‡บ๐Ÿ‡ธ USA